A new guide released this month explores how Australian teenagers are leading a shift in menstrual care preferences, with many embracing reusable products like menstrual discs as their first choice.
Contraline, a clinical-stage male contraception company, today announced that participants in the First-in-Human clinical trial of ADAM™ (“The ADAM Study”) have reached a critical milestone, demonstrating both safety and efficacy at the 24-month mark.
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics is pleased to provide the following update on its business activities for the three months to 31 March 2025 and subsequent to the period end.
Etira announced three presentations at the AACR Annual Meeting 2025 featuring new preclinical data on its LIPA-targeting compounds ERX-208 and ERX-315.
The International Society for MR Radiographers & Technologists (ISMRT) is proud to host its 2025 Annual Meeting from 9-12 May 2025 in Honolulu, Hawai‘i, in conjunction with the ISMRM Annual Meeting & Exhibition.
Looking to strengthen your communications strategy or learn how industry trailblazers achieve success? Or perhaps you want to hear about the inspirational journeys of those shaping today's PR world? That’s exactly what you’ll find—and more—in the newly launched EIN Presswire Substack, your go-to source for industry news, exclusive interviews, and strategies for press release writing and distribution.
SOMAÍ, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, today announced an exclusive partnership with SHERBINSKIS and BOUTIQ to exclusively manufacture and distribute their products across Europe and Australia.
